Business Combination, Period for Achievement of Cumulative Revenues For Payment of Contingent Consideration Liability

No definition available.

Name:	holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability
Namespace Prefix:	holx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Business Combination, Period for Payment of Contingent Consideration Liability

+ References

No definition available.

+ Details

Name:	holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
Namespace Prefix:	holx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value

+ References

No definition available.

+ Details

Name:	holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
Namespace Prefix:	holx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109124213&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109124213&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of intangible assets, excluding goodwill, acquired at the acquisition date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472

+ Details

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The amount of property, plant, and equipment recognized as of the acquisition date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 55
-Paragraph 37
-URI http://asc.fasb.org/extlink&oid=108330185&loc=d3e2207-128464

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472

+ Details

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

+ Details

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=holx_EmsorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=holx_FaxitronMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Business Combination - Narrative (Details) - USD ($) $ in Millions	Oct. 01, 2018	Jul. 31, 2018	Dec. 11, 2017	Dec. 29, 2018	Sep. 29, 2018
Business Acquisition [Line Items]
Goodwill				$ 2,562.9	$ 2,533.2
Emsor
Business Acquisition [Line Items]
Consideration transferred			$ 16.3
Purchase price withheld			$ 0.5	4.9
Period for payment of contingent consideration liabilities			18 months
Period of cumulative revenue to trigger payment of contingent consideration liability			2 years
Goodwill				5.7
Property, plant and equipment				6.0
Emsor \| Customer relationships
Business Acquisition [Line Items]
Identifiable intangible assets			$ 4.6
Faxitron
Business Acquisition [Line Items]
Consideration transferred		$ 89.5
Purchase price withheld		$ 11.7		$ 2.9
Period for payment of contingent consideration liabilities		1 year
Goodwill		$ 42.4
Faxitron \| Developed technology
Business Acquisition [Line Items]
Identifiable intangible assets		$ 44.9
Weighted average period		9 years
Faxitron \| In-process research and development
Business Acquisition [Line Items]
Identifiable intangible assets		$ 5.5
Faxitron \| In-process research and development \| Minimum \| Discount Rate
Business Acquisition [Line Items]
Intangible assets, fair value (percentage)		17.00%
Faxitron \| In-process research and development \| Maximum \| Discount Rate
Business Acquisition [Line Items]
Intangible assets, fair value (percentage)		19.00%
Faxitron \| Customer relationships
Business Acquisition [Line Items]
Identifiable intangible assets		$ 0.5
Weighted average period		9 years
Faxitron \| Trade names
Business Acquisition [Line Items]
Identifiable intangible assets		$ 2.3
Weighted average period		7 years
Focal Therapeutics
Business Acquisition [Line Items]
Consideration transferred	$ 120.1
Purchase price withheld	$ 14.0
Period for payment of contingent consideration liabilities	1 year
Goodwill	$ 30.4
Focal Therapeutics \| Developed technology
Business Acquisition [Line Items]
Identifiable intangible assets	$ 83.1
Weighted average period	11 years
Focal Therapeutics \| In-process research and development
Business Acquisition [Line Items]
Identifiable intangible assets	$ 11.4
Focal Therapeutics \| In-process research and development \| Minimum \| Discount Rate
Business Acquisition [Line Items]
Intangible assets, fair value (percentage)	15.50%
Focal Therapeutics \| In-process research and development \| Maximum \| Discount Rate
Business Acquisition [Line Items]
Intangible assets, fair value (percentage)	16.50%
Focal Therapeutics \| Trade names
Business Acquisition [Line Items]
Identifiable intangible assets	$ 2.7
Weighted average period	13 years